Publicaciones (12) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Leukemia, Vol. 37, Núm. 2, pp. 339-347

  2. Effects of Dietary Supplementation with a Ferulic Acid-Rich Bioactive Component of Wheat Bran in a Murine Model of Graft-Versus-Host Disease

    Nutrients, Vol. 15, Núm. 21

  3. Healthcare-associated infection prevention and control learning and teaching processes in european higher education institutions – a qualitative study

    Pielęgniarstwo Polskie, Núm. 3, Vol. 89, pp. 91-101

  4. Influence of Previous Mental State on Psychological Outcomes of Spanish Out-of-Hospital Professionals during the COVID-19 Pandemic

    International journal of environmental research and public health, Vol. 20, Núm. 4

  5. Oligodendrocyte origin and development in the zebrafish visual system

    Journal of Comparative Neurology, Vol. 531, Núm. 4, pp. 515-527

  6. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

    eClinicalMedicine, Vol. 65

  7. Predictors of the post-stroke status in the discharge from the hospital. Importance in nursing

    Enfermería global: revista electrónica trimestral de enfermería, Vol. 22, Núm. 1, pp. 1-37

  8. Preliminary results of customized bone graft made by robocasting hydroxyapatite and tricalcium phosphates for oral surgery

    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Vol. 135, Núm. 2, pp. 192-203

  9. REDOX Balance in Oligodendrocytes Is Important for Zebrafish Visual System Regeneration

    Antioxidants, Vol. 12, Núm. 12

  10. Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution

    Cancers, Vol. 15, Núm. 3

  11. The Five “Ws” of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When

    Cancers, Vol. 15, Núm. 17

  12. The anxiolytic drug opipramol inhibits insulin-induced lipogenesis in fat cells and insulin secretion in pancreatic islets

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 2, pp. 415-425